These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34125204)

  • 21. Can Physical Activity Reduce the Risk of Cognitive Decline in Apolipoprotein e4 Carriers? A Systematic Review.
    Perez-Lasierra JL; Casajús JA; Casasnovas JA; Arbones-Mainar JM; Lobo A; Lobo E; Moreno-Franco B; Gonzalez-Agüero A
    Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34299687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential Associations of Apolipoprotein E ε4 Genotype With Attentional Abilities Across the Life Span of Individuals With Down Syndrome.
    D'Souza H; Mason L; Mok KY; Startin CM; Hamburg S; Hithersay R; Baksh RA; Hardy J; Strydom A; Thomas MSC;
    JAMA Netw Open; 2020 Sep; 3(9):e2018221. PubMed ID: 32986108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits.
    Tangwongchai S; Supasitthumrong T; Hemrunroj S; Tunvirachaisakul C; Chuchuen P; Houngngam N; Snabboon T; Tawankanjanachot I; Likitchareon Y; Phanthumchindad K; Maes M
    Mol Neurobiol; 2018 Aug; 55(8):6449-6462. PubMed ID: 29307083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association Between Mentally Stimulating Activities in Late Life and the Outcome of Incident Mild Cognitive Impairment, With an Analysis of the APOE ε4 Genotype.
    Krell-Roesch J; Vemuri P; Pink A; Roberts RO; Stokin GB; Mielke MM; Christianson TJ; Knopman DS; Petersen RC; Kremers WK; Geda YE
    JAMA Neurol; 2017 Mar; 74(3):332-338. PubMed ID: 28135351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physical Activity as Moderator of the Association Between APOE and Cognitive Decline in Older Adults: Results from Three Longitudinal Cohort Studies.
    Stringa N; van Schoor NM; Milaneschi Y; Ikram MA; Del Panta V; Koolhaas CM; Voortman T; Bandinelli S; Wolters FJ; Huisman M
    J Gerontol A Biol Sci Med Sci; 2020 Sep; 75(10):1880-1886. PubMed ID: 32110803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Apolipoprotein E Genotype on Neurocognitive Function in Patients With Brain Metastases: An Analysis of NRG Oncology's RTOG 0614.
    Wefel JS; Deshmukh S; Brown PD; Grosshans DR; Sulman EP; Cerhan JH; Mehta MP; Khuntia D; Shi W; Mishra MV; Suh JH; Laack NN; Chen Y; Curtis AA; Laba JM; Elsayed A; Thakrar A; Pugh SL; Bruner DW
    Int J Radiat Oncol Biol Phys; 2024 Jul; 119(3):846-857. PubMed ID: 38101486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive and neural signatures of the APOE E4 allele in mid-aged adults.
    Evans S; Dowell NG; Tabet N; Tofts PS; King SL; Rusted JM
    Neurobiol Aging; 2014 Jul; 35(7):1615-23. PubMed ID: 24582638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution and clinical impact of apolipoprotein E4 in subjective memory impairment and early mild cognitive impairment.
    Cho H; Kim YE; Chae W; Kim KW; Kim JW; Kim HJ; Na DL; Ki CS; Seo SW
    Sci Rep; 2020 Aug; 10(1):13365. PubMed ID: 32770103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. APOE e4 genotype and cigarette smoking in adults with normal cognition and mild cognitive impairment: a retrospective baseline analysis of a national dataset.
    Kalapatapu RK; Delucchi KL
    Am J Drug Alcohol Abuse; 2013 Jul; 39(4):219-26. PubMed ID: 23808899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Link among apolipoprotein E E4, gait, and cognition in neurodegenerative diseases: ONDRI study.
    Sakurai R; Pieruccini-Faria F; Cornish B; Fraser J; Binns MA; Beaton D; Dilliott AA; Kwan D; Ramirez J; Tan B; Scott CJM; Sunderland KM; Tartaglia C; Finger E; Zinman L; Freedman M; McLaughlin PM; Swartz RH; Symons S; Lang AE; Bartha R; Black SE; Masellis M; Hegele RA; McIlroy W; ; Montero-Odasso M
    Alzheimers Dement; 2024 Apr; 20(4):2968-2979. PubMed ID: 38470007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modelling Decline in Cognition to Decline in Function in Alzheimer's Disease.
    Karcher H; Savelieva M; Qi L; Hummel N; Caputo A; Risson V; Capkun G; Alzheimer's Disease Neuroimaging Initiative
    Curr Alzheimer Res; 2020; 17(7):635-657. PubMed ID: 33032508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of APOE e4-allele and mental work demands on cognitive decline in old age: Results from the German Study on Ageing, Cognition, and Dementia in Primary Care Patients (AgeCoDe).
    Rodriguez FS; Roehr S; Pabst A; Kleineidam L; Fuchs A; Wiese B; Lühmann D; Brettschneider C; Wolfsgruber S; Pentzek M; van den Bussche H; König HH; Weyerer S; Werle J; Bickel H; Weeg D; Maier W; Scherer M; Wagner M; Riedel-Heller SG
    Int J Geriatr Psychiatry; 2021 Jan; 36(1):152-162. PubMed ID: 32819031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association Between Apolipoprotein E ε2 vs ε4, Age, and β-Amyloid in Adults Without Cognitive Impairment.
    Insel PS; Hansson O; Mattsson-Carlgren N
    JAMA Neurol; 2021 Feb; 78(2):229-235. PubMed ID: 33044487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein E Genotype Modifies the Association Between Cardiac Output and Cognition in Older Adults.
    Bown CW; Liu D; Osborn KE; Gupta DK; Mendes LA; Pechman KR; Hohman TJ; Wang TJ; Gifford KA; Jefferson AL
    J Am Heart Assoc; 2019 Aug; 8(15):e011146. PubMed ID: 31364446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of the Apolipoprotein E Genotype on Cognitive Change During a Multidomain Lifestyle Intervention: A Subgroup Analysis of a Randomized Clinical Trial.
    Solomon A; Turunen H; Ngandu T; Peltonen M; Levälahti E; Helisalmi S; Antikainen R; Bäckman L; Hänninen T; Jula A; Laatikainen T; Lehtisalo J; Lindström J; Paajanen T; Pajala S; Stigsdotter-Neely A; Strandberg T; Tuomilehto J; Soininen H; Kivipelto M
    JAMA Neurol; 2018 Apr; 75(4):462-470. PubMed ID: 29356827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and pathologic presentation in Parkinson's disease by apolipoprotein e4 allele status.
    Monsell SE; Besser LM; Heller KB; Checkoway H; Litvan I; Kukull WA
    Parkinsonism Relat Disord; 2014 May; 20(5):503-7. PubMed ID: 24582705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physical, social and productive leisure activities, cognitive decline and interaction with APOE-epsilon 4 genotype in Chinese older adults.
    Niti M; Yap KB; Kua EH; Tan CH; Ng TP
    Int Psychogeriatr; 2008 Apr; 20(2):237-51. PubMed ID: 18190728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular Pharmacogenomics and Cognitive Function in Patients with Schizophrenia.
    Ward KM; Kraal AZ; Flowers SA; Ellingrod VL
    Pharmacotherapy; 2017 Sep; 37(9):1122-1130. PubMed ID: 28605058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of an APOE polymorphism on cognitive function depends on age.
    Shin MH; Kweon SS; Choi JS; Lee YH; Nam HS; Park KS; Kim HN; Song HR; Kim BC; Choi SM; Oh SY; Jeong SK
    J Neurol; 2014 Jan; 261(1):66-72. PubMed ID: 24146255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Vitamin E and Cognitive Decline in Older Adults with and without the APOEɛ4 Allele: A Biracial Population-Based Community Study.
    Liu X; Finno CJ; Beck T; Dhana K; Tangney C; Desai P; Krueger K; Evans DA; Rajan KB
    J Alzheimers Dis; 2023; 96(3):1129-1138. PubMed ID: 37955092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.